Binge-eating disorder treatment goes online - feasibility, usability, and treatment outcome of an Internet-based treatment for binge-eating disorder: study protocol for a three-arm randomized controlled trial including an immediate treatment, a waitlist, and a placebo control group.
Binge-eating disorder
Cognitive behavioral therapy
Guided self-help
Internet-based treatment
Placebo
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
13 Feb 2019
13 Feb 2019
Historique:
received:
01
06
2018
accepted:
10
01
2019
entrez:
15
2
2019
pubmed:
15
2
2019
medline:
6
7
2019
Statut:
epublish
Résumé
Binge-eating disorder (BED) is characterized by recurrent episodes of loss of control over eating and is related to a higher prevalence of other mental disorders and somatic consequences associated with overweight and obesity. In community-based samples, 2-4% of women and 1-3% men are diagnosed with BED. Psychotherapeutic interventions focusing on maintenance factors of disturbed eating behavior have proven to be effective. However, treatment access is limited for a considerable number of patients with BED. A lack of specialized institutions and treatment resources, but also long distances to treatment facilities for people living in remote or rural areas are often causes of insufficient care. Internet-based guided self-help (GSH) programs have the potential to fill this gap. This project aims to develop and evaluate an Internet-based treatment for BED derived from an evidence-based manualized cognitive behavioral therapy (CBT). The primary goal is to test feasibility and suitability of the Internet-based program and to evaluate the treatment outcome in comparison to a pure and a placebo-inspired waitlist control group (i.e. reduction of binge-eating episodes and eating disorder pathology as primary outcome variables). In total, 60 women and men aged 18-70 years with a BED diagnosis will be recruited. The Internet-based GSH treatment comprises eight sessions followed by three booster sessions. The placebo-inspired waitlist control group receives weekly messages containing information increasing positive expectations regarding the treatment effects during the four-week waiting period. The pure waitlist control group receives weekly messages simply asking patients to fill in a short questionnaire. The access to evidence-based treatments for BED might be made easier using an Internet-based GSH approach. The present study protocol presents a randomized controlled trial. As well as evaluating the suitability and efficacy of the Internet-based GSH treatment, there will also be a prelimarily investigation on the influence of positive expectations (placebo) for a therapeutic intervention on core symptoms. German Clinical Trials Register, DRKS00012355 . Registered on 14 September 2017.
Sections du résumé
BACKGROUND
BACKGROUND
Binge-eating disorder (BED) is characterized by recurrent episodes of loss of control over eating and is related to a higher prevalence of other mental disorders and somatic consequences associated with overweight and obesity. In community-based samples, 2-4% of women and 1-3% men are diagnosed with BED. Psychotherapeutic interventions focusing on maintenance factors of disturbed eating behavior have proven to be effective. However, treatment access is limited for a considerable number of patients with BED. A lack of specialized institutions and treatment resources, but also long distances to treatment facilities for people living in remote or rural areas are often causes of insufficient care. Internet-based guided self-help (GSH) programs have the potential to fill this gap.
METHODS
METHODS
This project aims to develop and evaluate an Internet-based treatment for BED derived from an evidence-based manualized cognitive behavioral therapy (CBT). The primary goal is to test feasibility and suitability of the Internet-based program and to evaluate the treatment outcome in comparison to a pure and a placebo-inspired waitlist control group (i.e. reduction of binge-eating episodes and eating disorder pathology as primary outcome variables). In total, 60 women and men aged 18-70 years with a BED diagnosis will be recruited. The Internet-based GSH treatment comprises eight sessions followed by three booster sessions. The placebo-inspired waitlist control group receives weekly messages containing information increasing positive expectations regarding the treatment effects during the four-week waiting period. The pure waitlist control group receives weekly messages simply asking patients to fill in a short questionnaire.
DISCUSSION
CONCLUSIONS
The access to evidence-based treatments for BED might be made easier using an Internet-based GSH approach. The present study protocol presents a randomized controlled trial. As well as evaluating the suitability and efficacy of the Internet-based GSH treatment, there will also be a prelimarily investigation on the influence of positive expectations (placebo) for a therapeutic intervention on core symptoms.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trials Register, DRKS00012355 . Registered on 14 September 2017.
Identifiants
pubmed: 30760299
doi: 10.1186/s13063-019-3192-z
pii: 10.1186/s13063-019-3192-z
pmc: PMC6375147
doi:
Substances chimiques
Placebos
0
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
128Subventions
Organisme : Swiss Anorexia Nervosa Foundation
ID : 52-15
Références
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Clin Psychol Rev. 2006 Oct;26(6):657-78
pubmed: 15908088
Biol Psychiatry. 2007 Feb 1;61(3):348-58
pubmed: 16815322
Int J Eat Disord. 2007 Mar;40(2):102-13
pubmed: 17089420
Pediatrics. 2008 Mar;121(3):453-62
pubmed: 18310192
Int J Eat Disord. 2010 Apr;43(3):205-17
pubmed: 19402028
Behav Res Ther. 2009 Jul;47(7):628-35
pubmed: 19446793
J Adolesc Health. 2009 Jul;45(1):95-7
pubmed: 19541256
Psychol Methods. 2010 Sep;15(3):209-33
pubmed: 20822249
Clin Pract Epidemiol Ment Health. 2011 Mar 04;7:8-18
pubmed: 21552482
Behav Res Ther. 2011 Aug;49(8):482-91
pubmed: 21641580
Behav Res Ther. 2011 Sep;49(9):536-43
pubmed: 21723534
Appetite. 2012 Feb;58(1):88-97
pubmed: 21983051
Clin Psychol Rev. 2012 Jun;32(4):343-57
pubmed: 22504491
Curr Psychiatry Rep. 2012 Aug;14(4):432-46
pubmed: 22707016
Behav Res Ther. 2012 Dec;50(12):775-85
pubmed: 23099111
Trials. 2012 Nov 21;13:220
pubmed: 23171536
Biol Psychiatry. 2013 May 1;73(9):904-14
pubmed: 23290497
Int J Eat Disord. 2013 Jul;46(5):508-15
pubmed: 23658102
Int J Eat Disord. 2013 Sep;46(6):539-52
pubmed: 23674367
BMC Psychiatry. 2013 Aug 06;13:207
pubmed: 23919625
Psychiatr Prax. 2013 Sep;40(6):321-6
pubmed: 24008680
Curr Opin Psychiatry. 2013 Nov;26(6):543-8
pubmed: 24060914
Curr Opin Psychiatry. 2013 Nov;26(6):549-55
pubmed: 24060917
Behav Med. 2015;41(2):60-8
pubmed: 24354470
Behav Res Ther. 2014 Jul;58:36-42
pubmed: 24929926
BMC Med Inform Decis Mak. 2014 Jul 23;14:60
pubmed: 25056379
Behav Res Ther. 2014 Oct;61:55-60
pubmed: 25133855
J Med Internet Res. 2015 Mar 31;17(3):e85
pubmed: 25840591
World Psychiatry. 2015 Oct;14(3):270-7
pubmed: 26407772
World Psychiatry. 2015 Oct;14(3):310-1
pubmed: 26407786
J Clin Psychiatry. 2016 Aug;77(8):e968-74
pubmed: 27232527
PLoS One. 2016 Jun 22;11(6):e0157503
pubmed: 27331907
Behav Res Ther. 2016 Sep;84:9-13
pubmed: 27423373
Curr Opin Psychiatry. 2016 Nov;29(6):340-5
pubmed: 27662598
J Clin Psychiatry. 2017;78 Suppl 1:20-24
pubmed: 28125175
Int J Eat Disord. 2017 Mar;50(3):190-209
pubmed: 28134980
Am J Psychiatry. 2017 Feb 1;174(2):91-92
pubmed: 28142273
JAMA Psychiatry. 2017 Oct 1;74(10):987-995
pubmed: 28768334
Clin Psychol Psychother. 2018 Mar 23;:null
pubmed: 29573144
Control Clin Trials. 1988 Dec;9(4):365-74
pubmed: 3203526